A Saniabadi
Overview
Explore the profile of A Saniabadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muratov V, Lundahl J, Ulfgren A, Elvin K, Fehrman I, Ahlborg N, et al.
Int J Colorectal Dis
. 2006 Mar;
21(6):493-504.
PMID: 16538495
Background & Aims: Pilot studies have indicated a therapeutic role for an apheresis device (Adacolumn) that selectively adsorbs leukocytes in patients with inflammatory bowel diseases. It may also exert immunoregulatory...
2.
Sawada K, Kashiwamura S, Okamura H, Ohnishi K, Fukunaga K, Hirata I, et al.
Dig Liver Dis
. 2005 Jun;
37(7):515-21.
PMID: 15975539
Background And Aim: Selective granulocyte and monocyte/macrophage adsorptive apheresis is to increase the turnover of infected leucocytes and has increased CD4+ T cells, which are necessary for actions of interferon-alpha...
3.
Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang X, et al.
Leg Med (Tokyo)
. 2003 Aug;
3(2):84-94.
PMID: 12935528
In our recent report, it remained unclear whether or not triglyceride-rich lipoprotein remnants (RLP) were associated with the risk of sudden coronary death in younger cases without coronary atherosclerosis that...
4.
Hasson H, Saniabadi A, Alfano M, Trabattoni D, Ferrante P, Lillo F, et al.
J Biol Regul Homeost Agents
. 2002 May;
16(1):58-63.
PMID: 12003176
Current antiretroviral regimens (HAART) are generally effective in reducing viral replication to undetectable levels and inducing a raise in CD4 T cells. However, in approximately 5 to 15% of patients...
5.
Kawakami A, Tanaka A, Nakano T, Saniabadi A, Numano F
Horm Metab Res
. 2001 Apr;
33(2):67-72.
PMID: 11294495
Postprandial lipidemia, characterized by high plasma triglyceride-rich lipoprotein remnants, is associated with atherosclerosis. It has also been known that proliferation of vascular smooth muscle cells is crucial for the development...
6.
Lau C, McLaren M, Saniabadi A, Belch J
Scand J Rheumatol
. 1993 Jan;
22(3):97-101.
PMID: 8316776
Platelet activation may have a pathophysiological role in Raynaud's phenomenon (RP). However, previous studies have shown conflicting results. This may be related to patient selection and the choice of platelet...
7.
Belch J, Lau C, Saniabadi A, McLaren M, Forbes C
Am J Med
. 1991 Dec;
91(6):666-8.
PMID: 1721483
No abstract available.
8.
Bridges A, McLaren M, Saniabadi A, Fisher T, Belch J
Blood Coagul Fibrinolysis
. 1991 Jun;
2(3):447-52.
PMID: 1932530
There is a circadian variation in the time of onset of thrombotic disorders. The thrombotic tendency of blood is influenced by many factors including complex interactions between endothelial cells, platelets...
9.
Lau C, McLaren M, Saniabadi A, Scott N, Belch J
Clin Exp Rheumatol
. 1991 May;
9(3):271-3.
PMID: 1879086
Prostacyclin (PGI2) and its analogues are useful treatments for patients with secondary Raynaud's syndrome (RS). However, they have to be given intravenously, causing inconvenience to patients. Cicaprost is an orally...
10.
Belch J, Ansell D, Saniabadi A, Forbes C, Sturrock R
Prog Clin Biol Res
. 1987 Jan;
242:413-7.
PMID: 2444992
No abstract available.